|
BALTIMORE, MD—July 8, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the publication of its research findings on autologous hematopoietic stem cell transplantation (AHSCT).
AHSCT is an increasingly important therapy for a variety of malignancies, yet gaps exist in clinicians’ understanding of challenges that can hinder optimal patient outcomes. In an effort to help clinical members of hematology-oncology care teams maximize the benefits of AHSCT, Med-IQ conducted a comprehensive research study and published its findings in the CME/CE-certified report, Perspectives From the Frontlines of Stem Cell Mobilization: A Report of Current Evidence, In Practice Research, and National Survey Findings. This complimentary CME/CE publication integrates research findings with current medical literature to explore barriers that result in delayed initiation of AHSC collection and subsequent transplantation. It also provides evidence-based data on risk factors for AHSC mobilization, different mobilization strategies, clinical outcomes, and resource utilization.
“Stem cell transplant plays a powerful role in the treatment of patients with hematologic malignancies,” said Luciano J. Costa, MD, PhD, Associate Professor of Medicine and Director of Research of the BMT Program at the Medical University of South Carolina. “However, proper planning is imperative to achieve good outcomes. Our goal with this activity is to equip members of the hematology-oncology team with evidence-based data to better navigate the complexities of this therapeutic option.”
FACULTY
 |
|
Luciano J. Costa, MD, PhD
Associate Professor of Medicine
Director of Research, BMT Program
Medical University of South Carolina
Charleston, SC
|
 |
|
Shaji Kumar, MD
Professor of Medicine
Consultant, Division of Hematology
Mayo Clinic
Rochester, MN
|
 |
|
Hollie Devine, MSN, RN, ANP-BC, AOCNP
Nurse Practitioner
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, OH
|
Clinicians are invited to visit www.Med-IQ.com/a720 for complimentary access to this educational opportunity. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.
This activity is approved for AMA PRA Category 1 Credit™.
Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses.
This activity is supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management to improve team performance and patient outcomes. These initiatives have achieved improvements in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
close
